IGF1R and c-met as therapeutic targets for colorectal cancer

被引：37
作者：
Shali, Hajar [1 ,2 ]
Ahmadi, Majid [3 ,4 ]
Kafil, Hossein Samadi [5 ]
Dorosti, Abbasali [6 ]
Yousefi, Mehdi [3 ,4 ]
机构：
[1] Tabriz Univ Med Sci, Liver & Gastrointestinal Dis Res Ctr, Tabriz, Iran
[2] Tabriz Univ Med Sci, Students Res Comm, Tabriz, Iran
[3] Tabriz Univ Med Sci, Immunol Res Ctr, Tabriz, Iran
[4] Tabriz Univ Med Sci, Sch Med, Dept Immunol, Tabriz, Iran
[5] Tabriz Univ Med Sci, Drug Appl Res Ctr, Tabriz, Iran
[6] Tabriz Univ Med Sci, Imam Reza Hosp, Sch Med, Dept Anesthesiol, Tabriz, Iran
来源：
BIOMEDICINE & PHARMACOTHERAPY | 2016年 / 82卷
关键词：
Colorectal cancer; IGF1R; c-Met; Receptor tyrosine kinase; GROWTH-FACTOR-I; MONOCLONAL-ANTIBODY FIGITUMUMAB; FACTOR SIGNALING PATHWAY; FACTOR-BINDING-PROTEINS; INHIBITS TUMOR-GROWTH; FACTOR RECEPTOR; TYROSINE KINASE; COLON-CANCER; CARCINOMA CELLS; MEDIATED MIGRATION;
D O I：
10.1016/j.biopha.2016.05.034
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
The type 1 IGF receptor (IGF1R) and mesenchymal-epithelial transition (MET) are hetrodimeric and transmembrane receptor tyrosine kinases, which are frequently overexpressed by several tumor types, including colorectal cancer (CRC). These receptors bind to their specific ligands, insulin growth factors (IGFs) and hepatocyte growth factor (HGF), respectively, and promote signaling cascades which mediates many functions such as proliferation and protection against apoptosis, cell scattering, tumor cell motility, invasion and metastasis. In patients with metastatic colorectal cancer (mCRC), IGF1R and c-met expression confer resistance to cetuximab (monoclonal antibodies against EGFR). Therefore, the c-met and IGF1R are now an attractive novel target for anticancer therapy. In this review, we will describe correlation between two receptors and their activation effects in tumor cells, and finally introduce useful and available strategies for their targeting. (C) 2016 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码：528 / 536
页数：9
相关论文
共 50 条
[11]   Evaluation of IGF1R and phosphorylated IGF1R as targets in HER2-positive breast cancer cell lines and tumours [J].
Browne, Brigid C. ;
Eustace, Alex J. ;
Kennedy, Susan ;
O'Brien, Neil A. ;
Pedersen, Kasper ;
McDermott, Martina S. J. ;
Larkin, Annemarie ;
Ballot, Jo ;
Mahgoub, Thamir ;
Sclafani, Francesco ;
Madden, Stephen ;
Kennedy, John ;
Duffy, Michael J. ;
Crown, John ;
O'Donovan, Norma .
BREAST CANCER RESEARCH AND TREATMENT, 2012, 136 (03) :717-727
[12]   Evaluation of IGF1R and phosphorylated IGF1R as targets in HER2-positive breast cancer cell lines and tumours [J].
Brigid C. Browne ;
Alex J. Eustace ;
Susan Kennedy ;
Neil A. O’Brien ;
Kasper Pedersen ;
Martina S. J. McDermott ;
Annemarie Larkin ;
Jo Ballot ;
Thamir Mahgoub ;
Francesco Sclafani ;
Stephen Madden ;
John Kennedy ;
Michael J. Duffy ;
John Crown ;
Norma O’Donovan .
Breast Cancer Research and Treatment, 2012, 136 :717-727
[13]   MiR-185 enhances radiosensitivity of colorectal cancer cells by targeting IGF1R and IGF2 [J].
Afshar, Saeid ;
Najafi, Rezvan ;
Pashaki, Abdolazim Sedighi ;
Sharifi, Mohammadreza ;
Nikzad, Safoora ;
Gholami, Mohammad Hadi ;
Khoshghadam, Alireza ;
Amini, Razieh ;
Karimi, Jamshid ;
Saidijam, Massoud .
BIOMEDICINE & PHARMACOTHERAPY, 2018, 106 :763-769
[14]   The Role of the Insulin-like Growth Factor-1 Receptor (IGF-1R), Phosphatase and Tensin Homolog (PTEN), c-Met, and the PI3-Kinase Pathway in Colorectal Cancer [J].
Bagai, Rakesh ;
Ma, Patrick C. .
CURRENT COLORECTAL CANCER REPORTS, 2012, 8 (04) :243-253
[15]   HSF4 promotes tumor progression of colorectal cancer by transactivating c-MET [J].
Zhang, Wenjing ;
Zhang, Xuelian ;
Cheng, Peng ;
Yue, Kelin ;
Tang, Ming ;
Li, Yan ;
Guo, Qiang ;
Zhang, Yu .
MOLECULAR AND CELLULAR BIOCHEMISTRY, 2023, 478 (05) :1141-1150
[16]   Prognostic value of c-Met in colorectal cancer: A meta-analysis [J].
Liu, Yan ;
Yu, Xiao-Feng ;
Zou, Jian ;
Luo, Zi-Hua .
WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (12) :3706-3710
[17]   c-MET Overexpression in Colorectal Cancer: A Poor Prognostic Factor for Survival [J].
Lee, Su Jin ;
Lee, Jeeyun ;
Park, Se Hoon ;
Park, Joon Oh ;
Lim, Ho Yeong ;
Kang, Won Ki ;
Park, Young Suk ;
Kim, Seung Tae .
CLINICAL COLORECTAL CANCER, 2018, 17 (03) :165-169
[18]   Valproic acid, targets papillary thyroid cancer through inhibition of c-Met signalling pathway [J].
Fu, Yan-Tao ;
Zheng, Hai-Bo ;
Zhou, Le ;
Zhang, Da-Qi ;
Liu, Xiao-Li ;
Sun, Hui .
AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2017, 9 (06) :3138-3147
[19]   c-Met: A Promising Therapeutic Target in Bladder Cancer [J].
Feng, Yanfei ;
Yang, Zitong ;
Xu, Xin .
CANCER MANAGEMENT AND RESEARCH, 2022, 14 :2379-2388
[20]   Therapeutic Strategies for Ovarian Cancer in Point of HGF/c-MET Targeting [J].
Kim, Hyun Jung .
MEDICINA-LITHUANIA, 2022, 58 (05)
12345